We are live on ! Find out more
DFO

Duquesne Family Office Portfolio holdings

AUM $3.38B
1-Year Est. Return 61.92%
This Fund
S&P 500
This Quarter Est. Return
+18.27%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$1.5B
AUM Growth
+$655M
Cap. Flow
+$483M
Cap. Flow %
32.15%
Top 10 Hldgs %
53%
Holding
49
New
21
Increased
5
Reduced
–
Closed
7

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$48.9M
2
BMY icon
Bristol-Myers Squibb
BMY
+$48.6M
3
FDX icon
FedEx
FDX
+$47.3M
4
CCI icon
Crown Castle
CCI
+$40M
5
AA icon
Alcoa
AA
+$36.9M

Top Sells

Rank Stock Value
1
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$14.9M
2
EWY icon
iShares MSCI South Korea ETF
EWY
+$10.2M
3
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$9.69M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$9.67M
5
NOK icon
Nokia
NOK
+$6.51M

Sector Composition

Rank Sector Weight
1 Healthcare 22.17%
2 Communication Services 21.45%
3 Energy 18.62%
4 Industrials 11.33%
5 Technology 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
1
Alphabet (Google) Class C
GOOG
$3.9T
$261M 17.42%
9,364,971
+401,499
+4% +$10.2M
SLB icon
2
SLB Ltd
SLB
$77.8B
$89.5M 5.96%
993,000
– –
DAL icon
3
Delta Air Lines
DAL
$55.9B
$85.4M 5.69%
3,110,000
– –
AMZN icon
4
Amazon
AMZN
$2.5T
$62.9M 4.19%
3,154,000
– –
ILMN icon
5
Illumina
ILMN
$29.4B
$56M 3.73%
520,888
– –
FDX icon
6
FedEx
FDX
$74.5B
$51.3M 3.42%
+356,900
New +$47.3M
BMY icon
7
Bristol-Myers Squibb
BMY
$127B
$50.7M 3.38%
+954,200
New +$48.6M
TEVA icon
8
Teva Pharmaceuticals
TEVA
$35.9B
$49.7M 3.31%
+1,241,000
New +$48.9M
GILD icon
9
Gilead Sciences
GILD
$161B
$45.9M 3.06%
610,700
– –
AA icon
10
Alcoa
AA
$11.7B
$42.5M 2.83%
+1,664,586
New +$36.9M
WDAY icon
11
Workday
WDAY
$33.4B
$42M 2.8%
505,500
– –
HAL icon
12
Halliburton
HAL
$27.9B
$42M 2.8%
826,700
+193,000
+30% +$9.98M
CCI icon
13
Crown Castle
CCI
$32.7B
$39.7M 2.64%
+540,200
New +$40M
PXD
14
DELISTED
Pioneer Natural Resource Co.
PXD
$36.4M 2.43%
197,800
+54,800
+38% +$10.6M
SBAC icon
15
SBA Communications
SBAC
$18.4B
$35.7M 2.38%
+397,400
New +$34.1M
ENDP
16
DELISTED
Endo International plc
ENDP
$35.6M 2.37%
527,000
– –
PARA
17
DELISTED
Paramount Global Class B
PARA
$30.7M 2.05%
481,700
– –
DISH
18
DELISTED
DISH Network Corp.
DISH
$29.8M 1.99%
+515,000
New +$26.4M
VLO icon
19
Valero Energy
VLO
$89.8B
$29.2M 1.94%
+578,900
New +$24.4M
MPC icon
20
Marathon Petroleum
MPC
$90.3B
$29M 1.93%
+631,800
New +$24.3M
CBST
21
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$28.4M 1.9%
413,000
– –
AMGN icon
22
Amgen
AMGN
$203B
$26.4M 1.76%
231,000
– –
BIIB icon
23
Biogen
BIIB
$29.9B
$25.6M 1.7%
91,500
– –
EQT icon
24
EQT Corp
EQT
$33.2B
$25.6M 1.7%
+523,361
New +$24.7M
JNJ icon
25
Johnson & Johnson
JNJ
$635B
$21.5M 1.43%
235,000
+106,000
+82% +$9.77M
1
2

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return

Duquesne Family Office's Q4 2013 Portfolio in Review

As of Q4 2013, Duquesne Family Office held 49 positions worth $1.5B, up 77% from $846M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Duquesne Family Office deployed $483M of net new capital in Q4 2013, opening 21 new positions and adding to 5 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,241,000 shares worth $49.7M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $14.9M sold.

  • Duquesne Family Office's largest Q4 2013 buy was Teva Pharmaceuticals: 1,241,000 shares worth $49.7M.
  • Duquesne Family Office added most to Pioneer Natural Resource Co. in Q4 2013, an estimated $10.6M increase.
  • Duquesne Family Office fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q4 2013, selling an estimated $14.9M.
  • Duquesne Family Office's ten largest holdings make up 53% of its $1.5B portfolio in Q4 2013.
  • Duquesne Family Office opened 21 new positions and closed 7 in Q4 2013.
  • Duquesne Family Office's portfolio value rose 77% quarter-over-quarter to $1.5B.

Based on Duquesne Family Office's 13F filing for Q4 2013, filed 14 Feb 2014.